Business Description
California Nanotechnologies Corp
NAICS : 325998
SIC : 3799
ISIN : CA1304921010
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 3.3 | |||||
Debt-to-EBITDA | 3.99 | |||||
Interest Coverage | 8.79 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.49 | |||||
Beneish M-Score | -0.92 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 54.1 | |||||
3-Year EBITDA Growth Rate | 94.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.34 | |||||
9-Day RSI | 46.04 | |||||
14-Day RSI | 43.66 | |||||
6-1 Month Momentum % | 266.94 | |||||
12-1 Month Momentum % | 491.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.23 | |||||
Days Sales Outstanding | 45.69 | |||||
Days Payable | 89.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10 | |||||
Shareholder Yield % | -1.78 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.35 | |||||
Operating Margin % | 28.32 | |||||
Net Margin % | 3.36 | |||||
FCF Margin % | 6.24 | |||||
ROE % | 57.04 | |||||
ROA % | 5.42 | |||||
ROIC % | 58.82 | |||||
ROC (Joel Greenblatt) % | 21.5 | |||||
ROCE % | 20.37 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 46.98 | |||||
PEG Ratio | 1.31 | |||||
PS Ratio | 6.46 | |||||
PB Ratio | 37.59 | |||||
Price-to-Tangible-Book | 37.59 | |||||
Price-to-Free-Cash-Flow | 94.84 | |||||
Price-to-Operating-Cash-Flow | 47.44 | |||||
EV-to-EBIT | 96.71 | |||||
EV-to-EBITDA | 51.3 | |||||
EV-to-Revenue | 6.22 | |||||
EV-to-FCF | 102.97 | |||||
Price-to-Projected-FCF | 10.74 | |||||
Price-to-Median-PS-Value | 2.15 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.83 | |||||
Price-to-Graham-Number | 9.4 | |||||
Earnings Yield (Greenblatt) % | 1.03 | |||||
FCF Yield % | 1.04 | |||||
Forward Rate of Return (Yacktman) % | 20.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CANOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
California Nanotechnologies Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 5.413 | ||
EPS (TTM) ($) | -0.005 | ||
Beta | 0.5 | ||
Volatility % | 117.18 | ||
14-Day RSI | 43.66 | ||
14-Day ATR ($) | 0.082169 | ||
20-Day SMA ($) | 0.775849 | ||
12-1 Month Momentum % | 491.18 | ||
52-Week Range ($) | 0.1415 - 1.45 | ||
Shares Outstanding (Mil) | 42.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
California Nanotechnologies Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
California Nanotechnologies Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
California Nanotechnologies Corp Frequently Asked Questions
What is California Nanotechnologies Corp(CANOF)'s stock price today?
When is next earnings date of California Nanotechnologies Corp(CANOF)?
Does California Nanotechnologies Corp(CANOF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |